colorectal cancer trang 2 tải miễn phí từ TAILIEUCHUNG

"colorectal cancer" trang 2 - tải miễn phí từ Tailieuchung

Dose escalating study of cetuximab and 5-FU/ folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancer

Dose escalating study of cetuximab and 5-FU/ folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancer

8 23 1

FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab

FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab

9 41 1

Correlating tumor metabolic progression index measured by serial FDG PET-CT, apparent diffusion coefficient measured by magnetic resonance imaging (MRI) and blood genomics to patient’s outcome in advanced colorectal cancer: The CORIOLAN study

Correlating tumor metabolic progression index measured by serial FDG PET-CT, apparent diffusion coefficient measured by magnetic resonance imaging (MRI) and blood genomics to patient’s outcome in advanced colorectal cancer: The CORIOLAN study

8 47 1

Predicting response to vascular endothelial growth factor inhibitor and chemotherapy in metastatic colorectal cancer

Predicting response to vascular endothelial growth factor inhibitor and chemotherapy in metastatic colorectal cancer

14 64 1

The CAIRO4 study: The role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer – a randomized phase III study of the Dutch Colorectal Cancer Group (DCCG)

The CAIRO4 study: The role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer – a randomized phase III study of the Dutch Colorectal Cancer Group (DCCG)

7 41 1

A population-based cross-sectional study of colorectal cancer screening practices of firstdegree relatives of colorectal cancer patients

A population-based cross-sectional study of colorectal cancer screening practices of firstdegree relatives of colorectal cancer patients

11 56 1

Comparison of long-term outcomes between Lynch sydrome and sporadic colorectal cancer: A propensity score matching analysis

Comparison of long-term outcomes between Lynch sydrome and sporadic colorectal cancer: A propensity score matching analysis

13 39 1

LAD1 expression is associated with the metastatic potential of colorectal cancer cells

LAD1 expression is associated with the metastatic potential of colorectal cancer cells

12 15 1

Prognostic significance of MUC2, CDX2 and SOX2 in stage II colorectal cancer patients

Prognostic significance of MUC2, CDX2 and SOX2 in stage II colorectal cancer patients

13 18 1

Randomized phase II study of SOX+B-mab versus SOX+C-mab in patients with previously untreated recurrent advanced colorectal cancer with wild-type KRAS (MCSGO-1107 study)

Randomized phase II study of SOX+B-mab versus SOX+C-mab in patients with previously untreated recurrent advanced colorectal cancer with wild-type KRAS (MCSGO-1107 study)

10 22 1

Clinicopathological features of HER2 positive metastatic colorectal cancer and survival analysis of anti-HER2 treatment

Clinicopathological features of HER2 positive metastatic colorectal cancer and survival analysis of anti-HER2 treatment

9 8 1

LINC00022 acts as an oncogene in colorectal cancer progression via sponging miR-375-3p to regulate FOXF1 expression

LINC00022 acts as an oncogene in colorectal cancer progression via sponging miR-375-3p to regulate FOXF1 expression

15 7 1

$A phase Ib study of capecitabine and zivaflibercept followed by a phase II singlearm expansion cohort in chemotherapy refractory metastatic colorectal cancer$

A phase Ib study of capecitabine and zivaflibercept followed by a phase II singlearm expansion cohort in chemotherapy refractory metastatic colorectal cancer

9 75 0

Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologicallyselected advanced colorectal cancer patients: The CIFRA study protocol

Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologicallyselected advanced colorectal cancer patients: The CIFRA study protocol

9 39 0

Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: A meta-analysis and systematic review

Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: A meta-analysis and systematic review

13 62 1

Glycolysis is essential for chemoresistance induced by transient receptor potential channel C5 in colorectal cancer

Glycolysis is essential for chemoresistance induced by transient receptor potential channel C5 in colorectal cancer

9 19 1

A phase II study of Epirubicin in oxaliplatinresistant patients with metastatic colorectal cancer and TOP2A gene amplification

A phase II study of Epirubicin in oxaliplatinresistant patients with metastatic colorectal cancer and TOP2A gene amplification

5 23 1

Evaluation of serum and tissue levels of VAP-1 in colorectal cancer

Evaluation of serum and tissue levels of VAP-1 in colorectal cancer

8 43 1

Molecular and pathological characterization of the EZH2 rs3757441 single nucleotide polymorphism in colorectal cancer

Molecular and pathological characterization of the EZH2 rs3757441 single nucleotide polymorphism in colorectal cancer

6 30 1

Safety and efficacy of irinotecan, oxaliplatin, and capecitabine (XELOXIRI) regimen with or without targeted drugs in patients with metastatic colorectal cancer: A retrospective cohort study

Safety and efficacy of irinotecan, oxaliplatin, and capecitabine (XELOXIRI) regimen with or without targeted drugs in patients with metastatic colorectal cancer: A retrospective cohort study

12 8 1

Đầu
1
[ 2 ]
3
4
5
6
7
8
9
10
11
12
13
14
15
Cuối

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.